Fate Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

DB:F6T Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
10 Jan 25	Sell€9,057	Jerome Bressi	Individual	5,980	€1.51
10 Jan 25	Sell€13,099	Bahram Valamehr	Individual	8,705	€1.50
10 Jan 25	Sell€8,563	Cindy Tahl	Individual	5,654	€1.51
20 Dec 24	Buy€641,836	Redmile Group, LLC	Company	397,964	€1.61
20 Dec 24	Sell€550,986	Redmile Group, LLC	Company	341,633	€1.61

Insider Trading Volume

Insider Buying: F6T insiders have only sold shares in the past 3 months.

Ownership Breakdown

What is the ownership structure of F6T?
Owner Type	Number of Shares	Ownership Percentage
Private Companies	0	0%
Individual Insiders	1,800,868	1.58%
General Public	10,081,239	8.85%
Hedge Funds	12,872,946	11.3%
Institutions	89,139,280	78.3%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 15.5%.

Top Shareholders

Top 25 shareholders own 75.55% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
11.3%	Redmile Group, LLC	12,872,946	€18.9m	-2.25%	1.19%
9.61%	BlackRock, Inc.	10,941,582	€16.1m	4.47%	no data
9.07%	The Vanguard Group, Inc.	10,333,033	€15.2m	-0.68%	no data
4.25%	Bellevue Asset Management AG	4,839,779	€7.1m	0%	0.09%
3.85%	Citadel Advisors LLC	4,382,257	€6.4m	2.34%	0.01%
3.12%	Deerfield Management Company, L.P. Series C	3,555,871	€5.2m	0%	0.1%
2.97%	Johnson & Johnson Innovation - JJDC, Inc.	3,379,064	€5.0m	0%	1.3%
2.86%	Baker Bros. Advisors LP	3,258,402	€4.8m	8.69%	0.04%
2.68%	EcoR1 Capital, LLC	3,049,405	€4.5m	0%	0.19%
2.54%	Dimensional Fund Advisors LP	2,898,377	€4.3m	10.7%	no data
2.29%	Morgan Stanley, Investment Banking and Brokerage Investments	2,607,237	€3.8m	-1.84%	no data
2.16%	Vestal Point Capital, LP	2,465,000	€3.6m	46.3%	0.21%
2.09%	Goldman Sachs Group, Investment Banking and Securities Investments	2,380,020	€3.5m	-8.51%	no data
1.96%	State Street Global Advisors, Inc.	2,227,295	€3.3m	-57.6%	no data
1.96%	Geode Capital Management, LLC	2,226,967	€3.3m	-1.39%	no data
1.63%	Tang Capital Management, LLC	1,855,954	€2.7m	165%	0.16%
1.48%	OrbiMed Advisors LLC	1,680,580	€2.5m	0%	0.04%
1.39%	Jacobs Levy Equity Management Inc	1,586,987	€2.3m	-0.06%	0.01%
1.35%	D. E. Shaw & Co., L.P.	1,536,633	€2.3m	-54.5%	no data
1.32%	JP Morgan Asset Management	1,503,203	€2.2m	-11.3%	no data
1.29%	Acadian Asset Management LLC	1,473,792	€2.2m	-8.01%	no data
1.25%	Woodline Partners LP	1,422,785	€2.1m	-53.6%	0.01%
1.21%	Superstring Capital Management LP	1,379,556	€2.0m	-5.96%	1.76%
0.97%	UBS Asset Management AG	1,103,393	€1.6m	102%	no data
0.95%	Walleye Capital LLC	1,083,092	€1.6m	1,500%	0.01%

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/02/19 22:37
End of Day Share Price	2025/02/19 00:00
Earnings	2024/09/30
Annual Earnings	2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Fate Therapeutics, Inc. is covered by 32 analysts. 15 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Jack Allen	Baird
Peter Lawson	Barclays
Etzer Darout	BMO Capital Markets Equity Research